Shortsell.net [Beta]

Janux Therapeutics

JANX

Janux Therapeutics has been a target of short sellers for a while. The current short interest of 8.71% is significantly below the average of the last 12 months (12.60%).

Short Interest Trend
Share Price
Total NSP
8.71%
-0.59%
vs. last month